Answers are grounded in this paper and cite their sources.
This case series highlights the occurrence of rare, but potentially severe, intraocular inflammation associated with faricimab therapy. Although these findings do not prove causality and can only generate hypotheses for future investigations, these results suggest the importance of continuous surveillance and monitoring for patients undergoing faricimab therapy to promptly identify and manage potential adverse events.
No takes yet. Share an insight, caveat, or question.
Cozzi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: